eligibility for clinicaltrials:NCT01227408 [clinicaltrials_resource:f627520ed9412be48f124f86c49b814c]
eligibility [clinicaltrials_vocabulary:eligibility]
eligibility for clinicaltrials:NCT01227408 [clinicaltrials_resource:f627520ed9412be48f124f86c49b814c]
Bio2RDF identifier
f627520ed9412be48f124f86c49b814c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f627520ed9412be48f124f86c49b814c
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
gender [clinicaltrials_vocabulary:gender]
healthy volunteers [clinicaltrials_vocabulary:healthy-volunteers]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
minimum age [clinicaltrials_vocabulary:minimum-age]
text [clinicaltrials_vocabulary:text]
Inclusion Criteria:
...... h doxorubicin and/or a taxane.
identifier
clinicaltrials_resource:f627520ed9412be48f124f86c49b814c
title
eligibility for clinicaltrials:NCT01227408
@en
type
label
eligibility for clinicaltrials ...... 7520ed9412be48f124f86c49b814c]
@en